Skip to main content

Inflammatory Mediators in Neonatal Asphyxia and Infection

  • Chapter
Neonatology

Abstract

Inflammatory mediators produced in response to hypoxic-ischemic (H-I) injury and infection in the newborn, include multi-potent cytokines and chemokines released by a variety of somatic and bone marrow-derived cells both locally, in the brain and systemically, in the circulation. Pro-inflammatory cytokines, such as interleukin (IL)-1, IL-6, IL-18, interferon (IFN)-γ and tumor necrosis factor (TNF)-α, are small polypeptides secreted in response to cellular injury and inflammation. Cytokines trigger somatic and immune cell activation, differentiation and death after signaling through their cognate receptors. Chemokines, such as CCL2 and CXCL8, are chemotactic cytokines that induce cells of the innate and adaptive immune system to leave the blood stream and migrate to sites of injury in the central nervous system (CNS) and in the periphery [1]. Cytokines and chemokines are considered critical mediators of brain damage and clinical indicators of overwhelming sepsis in the newborns. We review the cellular origin and role of cytokines and chemokines in these diseases. We also discuss treatment modalities that may interrupt these inflammatory cascades. A better understanding of the role of cytokines and chemokines in response to H-I injury and infection is likely to improve the outcome and long-term prognosis of these diseases in the newborn period.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Glass HC, Bonifacio SL, Chau V et al (2008). Recurrent postnatal infections are associated with progressive white matter injury in premature infants. Pediatrics 122: 299–305

    Article  PubMed  Google Scholar 

  2. Hagberg H, Mallard C (2005) Effect of inflammation on central nervous system development and vulnerability. Curr Opin Neurol 18: 117–123

    Article  PubMed  CAS  Google Scholar 

  3. Xanthou M (2006) Proinflammatory cytokines and chemokines in neonatal brain damage. Curr Ped Rev 2: 3–15

    Article  CAS  Google Scholar 

  4. Diaz-Alvarez A, Hilario E, de Cerio FG et al (2007) Hypoxic-Ischemic injury in the immature brain-key vascular and cellular players. Neonatology 92: 227–235

    Article  Google Scholar 

  5. Laing, KJ, Secombes CJ (2004). Chemokines. Dev Comp Immunol 28: 443–460

    Article  CAS  Google Scholar 

  6. Dammann O, O’Shea MT (2008) Cytokines and perinatal brain damage. In: Spitzer AR, White RD (eds) Neuroprotection in the newborn. Elsevier Saunders, Philadelphia, pp 643–663

    Google Scholar 

  7. Vanucci RC, Perlman JM (1997) Interventions for perinatal hypoxic-ischemic encephalopathy. Pediatrics 100: 1004–1014

    Article  Google Scholar 

  8. Okazaki K, Nishida A, Kato M et al (2006) Elevation of cytokine concentrations in asphyxiated neonates. Biol Neonate 89: 183–189

    Article  PubMed  CAS  Google Scholar 

  9. Florio P, Perrone S, Luisi S et al (2003) Activin-A plasma levels at birth: an index of fetal hypoxia in preterm newborn. Pediatr Res 54: 696–700

    Article  PubMed  CAS  Google Scholar 

  10. Petrakou E, Mouchtouri A, Levi A et al (2007) Interleukin-8 and monocyte chemotactic protein-1 mRNA expression in perinatally infected and asphyxiated preterm neonates. Neonatology 91: 107–113

    Article  PubMed  CAS  Google Scholar 

  11. Adams-Chapman I, Stoll BJ (2006) Neonatal infection and longterm neurodevelopmental outcome in the preterm infant. Curr Opin Infect Dis 19: 290–297

    Article  PubMed  Google Scholar 

  12. Levy O (2007) Innate Immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 7: 379–389

    Article  PubMed  CAS  Google Scholar 

  13. Medzhitov R (2007) Recognition of microorganisms and activation of the immune response. Nature 18: 819–826

    Article  Google Scholar 

  14. Maxwell NC, Davies PL, Kotecha S (2006) Antenatal infection and inflammation: what’s new? Curr Opin Infect Dis 19: 253–258

    Article  PubMed  Google Scholar 

  15. Dammann O, Leviton A (1997) Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 42: 1–8

    Article  PubMed  CAS  Google Scholar 

  16. Ganz T (2004) Antimicrobial polypeptides. J Leukoc Biol 75: 34–38

    Article  PubMed  CAS  Google Scholar 

  17. Ouellette AJ (2006). Paneth cell alpha-defensin synthesis and function. Curr Top Microbiol Immunol 306: 1–25

    Article  PubMed  CAS  Google Scholar 

  18. Ayabe T, Satchell D, Wilson CL et al (2000). Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol 1: 113–118

    Article  PubMed  CAS  Google Scholar 

  19. Salzman NH, Polin RA, Harris MC et al (1998) Enteric defensin expression in necrotizing enterocolitis. Pediatr Res 44: 20–26

    Article  PubMed  CAS  Google Scholar 

  20. Haeney M (1994) Infection determinants at extremes of age. J Antimicrob Chemother 34: 1–9

    Article  PubMed  Google Scholar 

  21. Adkins B (1999) T-cell function in newborn mice and humans. Immunol Today 20: 330–335

    Article  PubMed  CAS  Google Scholar 

  22. Mayer L (2003) Mucosal immunity. Pediatrics 111: 1595–1600

    PubMed  Google Scholar 

  23. Arnon S, Litmanovitz I (2008) Diagnostic tests in neonatal sepsis. Curr Opin Infect Dis 21: 223–227

    Article  PubMed  Google Scholar 

  24. Yerkovich J, Wikstrom ME, Suriyaarachchi D et al (2007) Postnatal development of monocyte cytokine response to bacterial lipopolysaccharide. Ped Res 62: 547–552

    Article  CAS  Google Scholar 

  25. Tatad AMF, Nesin M, Peoples J et al (2008) Cytokine Expression in Response to Bacterial Antigens in Preterm and Term Infant Cord Blood Monocytes. Neonatology 94: 8–15

    Article  PubMed  CAS  Google Scholar 

  26. Zhao J, Kim KD, Yang X et al (2008) Hyper-innate responses in neonates lead to increased morbidity and mortality after infection. PNAS USA 21: 7528–7533

    Article  Google Scholar 

  27. Levy E, Xanthou G, Petrakou E et al (2009) Distinct roles of TLR4 and CD14 in LPS-induced inflammatory responses of neonates. Pediatr Res 66: 179–184

    Article  PubMed  CAS  Google Scholar 

  28. Ramaswamy, V, Horton J, Vandermeer B et al (2009) Systematic review of biomarkers of brain injury in term neonatal encephalopathy. Pediatr Neurol 40: 215–226

    Article  PubMed  Google Scholar 

  29. Feldman M, Maini RN (2001) Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol 19: 163–196

    Article  Google Scholar 

  30. Schnitzler F, Fidder H, Ferrante M et al (2009). Long-term outcome of treatment with infliximab in 614 patients with Crohn’s disease: results from a single centre cohort. Gut 58: 492–500

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Italia

About this chapter

Cite this chapter

Xanthou, M., Niklas, V. (2012). Inflammatory Mediators in Neonatal Asphyxia and Infection. In: Buonocore, G., Bracci, R., Weindling, M. (eds) Neonatology. Springer, Milano. https://doi.org/10.1007/978-88-470-1405-3_110

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-1405-3_110

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-1404-6

  • Online ISBN: 978-88-470-1405-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics